Ontology highlight
ABSTRACT: Importance
In Huntington disease (HD), mutation severity is defined by the length of the CAG trinucleotide sequence, a well-known predictor of clinical onset age. The association with disease trajectory is less well characterized. Quantifiable summary measures of trajectory applicable over decades of early disease progression are lacking. An accurate model of the age-CAG association with early progression is critical to clinical trial design, informing both sample size and intervention timing.Objective
To succinctly capture the decades-long early progression of HD and its dependence on CAG repeat length.Design, setting, and participants
Prospective study at 4 academic HD treatment and research centers. Participants were the combined sample from the TRACK-HD and Trac
SUBMITTER: Langbehn DR
PROVIDER: S-EPMC6692683 | biostudies-literature | 2019 Nov
REPOSITORIES: biostudies-literature